(Q44564473)

English

Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 250 invasive Streptococcus pneumoniae isolates from France

scientific article published on 27 August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 250 invasive Streptococcus pneumoniae isolates from France (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

author name string

J W Decousser

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

P Pina

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

F Picot

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

P Y Allouch

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

27 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

561-565

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, a

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of faropenem against respiratory pathogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparison

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global antibiotic resistance in Streptococcus pneumoniae

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of infections due to antibiotic-resistant Streptococcus pneumoniae

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in-vitro activity of faropenem, a novel oral penem

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant Streptococcus pneumoniae

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial activity of faropenem, a new oral penem, against lower respiratory tract pathogens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000-2001: a comparison with other beta-lactam agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of the in-vitro activity of levofloxacin against Streptococcus pneumoniae.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12942341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10096-003-0990-7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44564473&oldid=2206746870"